Respiratory Disease Testing Market Report 2026

Respiratory Disease Testing Market Overview

• Respiratory Disease Testing market size has reached to $3.74 billion in 2025 • Expected to grow to $4.93 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Surging Prevalence Of Respiratory Diseases Sparks Growth In The Respiratory Disease Testing Market • Market Trend: Innovative Pulmonary Function Testing In The Respiratory Disease Testing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Respiratory Disease Testing Market?

Respiratory disease testing refers to the treatment process of testing for various respiratory diseases using physical examinations. It helps diagnose the lung condition and measures how fast it can blow air out, so the test's results can assist a clinician in diagnosing respiratory disease even before a patient experience symptom. The main types of tests involved in respiratory disease testing are imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests refer to a subset of diagnostic procedures that provide in-depth images of various bodily regions. The products used are lung volume, imaging, spirometry, peak flow, blood gas, and others. It is applied for several applications such as chronic obstructive pulmonary disease, lung cancer, asthma, female tuberculosis, and others used in hospitals, physician clinics, clinical laboratories, and others.

What Is The Respiratory Disease Testing Market Growth Forecast?

The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.93 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for rapid and accurate respiratory diagnostics, rising investments in diagnostic infrastructure, expansion of home-based respiratory testing, growing integration of ai-driven diagnostic tools, increasing focus on population health management. Major trends in the forecast period include increasing adoption of early diagnostic testing solutions, rising use of in-vitro diagnostic respiratory tests, growing integration of digital pulmonary monitoring tools, expansion of point-of-care respiratory testing, enhanced focus on preventive respiratory care.

Global Respiratory Disease Testing Market Segmentation

1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests 2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products 3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Applications 4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-Users Subsegments: 1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans 2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests 3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests

What Is The Driver Of The Respiratory Disease Testing Market?

The rising prevalence of respiratory diseases will boost the respiratory disease testing market going forward. Respiratory diseases refer to medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Respiratory disease testing is primarily used for the early detection and diagnosis of respiratory conditions, which can lead to earlier treatment and management. This can help prevent the progression of the disease and is also essential for controlling the spread of infectious respiratory diseases and reducing the risk of complications. For instance, in June 2025, according to the Office for Health Improvement and Disparities (OHID), a UK-based government department, the rate of emergency admissions for respiratory disease in England increased by 7% from the financial year ending 2023 to the financial year ending 2024. Therefore, the rising prevalence of respiratory diseases is driving the respiratory disease testing industry.

Key Players In The Global Respiratory Disease Testing Market

Major companies operating in the respiratory disease testing market are Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc.

Global Respiratory Disease Testing Market Trends and Insights

Major companies operating in the respiratory disease testing market are focused on developing advanced products, such as pulmonary function testing, to gain a competitive edge in the market. Pulmonary function tests are a group of tests that measure how well the lungs are working and how well a person can breathe. For instance, in March 2023, Vitalograph Ltd., a UK-based provider of respiratory diagnostics, launched VitaloPFT. The VitaloPFT Series delivers advanced respiratory diagnostic solutions through a range of detailed pulmonary function testing options. It offers healthcare providers a cost-effective solution for advanced respiratory diagnostics, enabling them to deliver high-quality care. It features an intuitive interface and user-friendly design that simplifies the PFT process for healthcare professionals, making it easy to operate and navigate.

What Are Latest Mergers And Acquisitions In The Respiratory Disease Testing Market?

In January 2023, CAIRE Inc., a US-based medical supply and manufacturing company, acquired MGC Diagnostics Holdings for an undisclosed amount. With this acquisition, CAIRE Inc. wants to increase the scope of its product line, diversify its income sources by adding cardiorespiratory diagnostic products to its portfolio, and strengthen its position as a market leader in medical technology for respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc. is a US-based medical technology company that provides cardiorespiratory diagnostic solutions and respiratory disease testing products.

Regional Outlook

North America was the largest region in the respiratory disease testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Respiratory Disease Testing Market?

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Respiratory Disease Testing Market Report 2026?

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.